Jamie Brush
Senior Associate @ Frazier Healthcare Partners
Menlo Park, United States
Jamie Brush is a post-ipo equity investor at Frazier Healthcare Partners in Menlo Park focused on Health Care and Therapeutics. James W. Brush is based out of Menlo Park, California. and is the General Partner and Portfolio Manager at Frazier Life Sciences. James previously worked at Boston Consulting Group as management consultant. James W. Brush attended the University of Southern California.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Jamie Brush invests in
Stages Jamie Brush invests in
Countries Jamie Brush invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Gritstone Oncology is a clinical-stage biotech company developing tumor-specific cancer immunotherapies to fight multiple cancer types. Its approach seeks to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy tumor cells by targeting tumor-specific neoantigens. GritstoneOncology is headquartered in Emeryville, California, with key functions located in Cambridge, Massachusetts, and Pleasanton, California. It was founded in August 2015 and is listed on the Nasdaq Global Select Market under the ticker symbol GRTS. | $55M / Post-IPO Equity / Sep 16, 2021 |
Co-Investors
Founded in 1991, Frazier Healthcare Partners is a leading provider of growth capital to healthcare companies. The firm has over $2B under management and has made investments in over 170 healthcare companies, with investment types ranging from company creation and venture capital to growth buyouts and leveraged recapitalizations.Frazier’sexperienced team takes an active approach to helping build portfolio companies, leveraging the team’s deep domain expertise and expansive network of healthcare executives, advisors, and industry thought leaders. The firm’s Growth Buyout team invests in profitable companies focusing on healthcare services, pharmaceutical services, medical products, and related sectors. The firm’s Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation.
Frazier Healthcare Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Nathan Every
General Partner
|
|||
|
Patrick Heron
General Partner
|
|||
|
Tadataka Yamada
Senior Entrepreneur in Residence
|
|||
|
Alan D. Frazier
Managinig Partner, Founder & Chairman
|
|||
|
Bob Baltera
Entrepreneurs In Residence
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Jamie Brush invest in?
Jamie Brush invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Post-IPO Equity stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jamie Brush?
Public channels for Jamie Brush include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jamie Brush last invest?
The most recent investment recorded for Jamie Brush closed in Sep 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!